Genetix Biotherapeutics Inc.

In News

Genetix Biotherapeutics and the National Football League Alumni Association Announce Partnership to Increase Awareness for Sickle Cell Disease and Transformative Treatment Options - Business Wire

Business Wire - Aug 18, 2026

Merck Becomes Sole Testing Provider for Genetix Biotherapeutics’ FDA-Approved Gene Therapies - Yahoo Finance

Yahoo Finance - May 07, 2026

A year after distressed buyout, what’s become of Somerville’s Bluebird Bio? - The Boston Globe

The Boston Globe - Jul 02, 2026

Lonza, Genetix Bio Extend Commercial Mfg. Pact for ZYNTEGLO - Contract Pharma

Contract Pharma - Mar 23, 2026

Genetix Announces 2025 Commercial Performance Results and Outlines 2026 Strategic Priorities - BioSpace

BioSpace - Mar 02, 2026

Minaris and Genetix Biotherapeutics Expand Manufacturing Partnership to Support Commercial Supply for LYFGENIA™ (lovotibeglogene autotemcel) - PR Newswire

PR Newswire - Jan 12, 2026

After buyout, bluebird bio hatches familiar new branding as Genetix Biotherapeutics - Fierce Pharma

Fierce Pharma - Sep 18, 2025

Genetix Biotherapeutics and SPIMACO Announce Strategic Agreement to Commercialize and Manufacture LYFGENIA™ & ZYNTEGLO™ in Saudi Arabia and the Broader Middle East Region - Business Wire

Business Wire - Jun 23, 2026

Bluebird bio flies to pastures new with Genetix rebranding - Pharmaceutical Technology

Pharmaceutical Technology - Sep 19, 2025

Genetix Biotherapeutics, Inc. Stock (BLUE) - Quote Nasdaq - marketscreener.com

marketscreener.com - Sep 27, 2025

bluebird bio Rebrands as Genetix Biotherapeutics - citybiz

citybiz - Sep 18, 2025

Orsini Now Distributing Gene Therapies LYFGENIA™, ZYNTEGLO™, SKYSONA™ - BioSpace

BioSpace - Feb 26, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment